Equivariant Shape-Conditioned Generation of 3D Molecules for Ligand-Based Drug Design
Shape-based virtual screening is widely employed in ligand-based drug design to search chemical libraries for molecules with similar 3D shapes yet novel 2D chemical structures compared to known ligands. 3D deep generative models have the potential to automate this exploration of shape-conditioned 3D chemical space; however, no existing models can reliably generate valid drug-like molecules in conformations that adopt a specific shape such as a known binding pose. We introduce a new multimodal 3D generative model that enables shape-conditioned 3D molecular design by equivariantly encoding molecular shape and variationally encoding chemical identity. We ensure local geometric and chemical validity of generated molecules by using autoregressive fragment-based generation with heuristic bonding geometries, allowing the model to prioritize the scoring of rotatable bonds to best align the growing conformational structure to the target shape. We evaluate our 3D generative model in tasks relevant to drug design including shape-conditioned generation of chemically diverse molecular structures and shape-constrained molecular property optimization, demonstrating its utility over virtual screening of enumerated libraries.
Code (1)
Tasks
Drug DesignvalidMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Shape-conditioned 3D Molecule Generation via Equivariant Diffusion Models
Ligand-based drug design aims to identify novel drug candidates of similar shapes with known active molecules. In this paper, we formulated an in silico shape-conditioned molecule generation problem to generate 3D molecu…
3D Molecule GenerationDrug DesignPILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling
The generation of ligands that both are tailored to a given protein pocket and exhibit a range of desired chemical properties is a major challenge in structure-based drug design. Here, we propose an in-silico approach fo…
Drug DesignDrug DiscoverySynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles
We present SynLaD, a latent diffusion framework for small-molecule generation that unifies ligand-based drug design objectives (what to make) with synthetic accessibility (how to make it). Current models typically optimi…
Structure-guided molecular design with contrastive 3D protein-ligand learning
Structure-based drug discovery faces the dual challenge of accurately capturing 3D protein-ligand interactions while navigating ultra-large chemical spaces to identify synthetically accessible candidates. In this work, w…
Contrastive LearningDrug DiscoveryFlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling
Structure-based drug design (SBDD), which aims to generate 3D ligand molecules binding to target proteins, is a fundamental task in drug discovery. Existing SBDD methods typically treat protein as rigid and neglect prote…
Data AugmentationDrug DesignDrug Discovery